Source Report
Research Question
Using Oklo's SEC filings (10-K, 10-Q, proxy statements), analyze its current cash position, quarterly burn rate, and projected funding runway. Identify any equity raises, warrant exercises, or debt facilities announced post-SPAC merger. What are publicly estimated milestones that could trigger additional funding needs or dilution events, and how does Oklo's capital structure (including Sam Altman's stake and institutional holders) compare to peer pre-revenue clean energy SPACs at similar stages?
Current Cash Position and Quarterly Burn Rate
Oklo ended Q3 2025 (Sep 30) with $410 million in cash equivalents plus $512 million in short-term marketable debt securities, creating a $1.18 billion liquidity fortress built through aggressive equity sales that auto-convert hype into working capital via at-the-market (ATM) programs—unlike traditional lenders, this mechanism lets Oklo tap daily trading volume without fixed pricing, minimizing discount but amplifying overhang risk as shares outstanding ballooned 13% YTD to 156 million.[1][2]
- Cash grew from $97 million (Dec 2024) via $460 million June public offering (7.7 million shares at $60) netting $441 million, plus $540 million ATM sales (7.4 million shares at ~$73 average) netting $526 million; prior SPAC (May 2024) added $276 million gross.[3][1]
- Burn: $49 million YTD ops cash (Q3 quarterly ~$18 million, up from $38 million FY2024 annual); guided $65-80 million full-year 2025 amid R&D ramp for Aurora reactors and Atomic Alchemy integration.[1]
For entrants, Oklo's ATM moat demands scale—small players can't issue without crashing bids, forcing slower VC drips vulnerable to milestone misses.
Projected Funding Runway
At $70 million midpoint burn, Oklo's $1.18 billion liquidity yields ~17 months runway into mid-2027, but management affirms "at least 12 months" post-filing while signaling more raises via $3.5 billion shelf (including $1.5 billion ATM filed Dec 2025)—this perpetual tap works because nuclear timelines (NRC licensing, fuel fab) stretch 3-5 years, letting Oklo dilute incrementally without panic pricing unlike cash-strapped peers.[1][2]
- No debt/warrants post-SPAC; sole liability is $25 million right-of-first-refusal (non-refundable power prepayment).
- FY2024 burn $38 million on $275 million liquidity (7+ months); Q3 2025 acceleration ties to $82 million YTD opex (R&D $34 million, G&A $48 million).[3]
New players face "runway cliff"—Oklo's public status enables rolling dilution; privates burn out pre-NRC without Altman-like backers.
Post-SPAC Funding Events
Post-May 2024 SPAC ($850 million pre-money valuation via AltC), Oklo executed three dilutive raises totaling ~$1.5 billion net, converting stock volatility into capex for fuel recycling and Ohio site prep—June's fixed-price offering locked gains at $60 peak, while ATMs rode 2025 rally to $73 average, but no warrant exercises or debt noted, keeping structure founder-friendly with earnouts vesting on $12-16 triggers (14.7 million shares issued).[2][1]
- June 2025: $460 million gross public (8.7 million shares total incl. overallotment).
- Aug-Sep 2025: $540 million ATM (7.4 million shares).
- No debt facilities; Atomic Alchemy buy (Feb 2025) was $1 million cash + 1.1 million shares.
Competitors must match this velocity—SPAC alums like Oklo refinance via shelves, trapping non-publics in down rounds.
Public Milestones Triggering Funding/Dilution
Oklo's 2026-2027 catalysts—NRC Phase I pre-app complete (Jul 2025), DOE Idaho pilot fuel load (2026), Aurora COL filing (2026), Ohio groundbreaking (post-Meta prepay 2026)—could unlock $100s millions in PPAs but trigger $500+ million per-plant capex, forcing shelf draws if stock dips below $50; Meta/Equinix deals mandate milestones by Jul 2026 or prepays revert to debt, flipping funding from equity to covenants.[4]
- Fuel recycling scale-up, HALEU sourcing delays likely need $1-2 billion by 2030.
- Dilution baked in: Shares up 13% YTD; $3.5 billion shelf eyes 20-30 million more at current $100+ prices.
Entrants time raises pre-milestone—Oklo's path shows missing NRC hits shelves at discounts, eroding 20-50% value.
Capital Structure vs. Pre-Revenue Peers
Oklo's ~156 million fully-diluted shares (no dual-class post-SPAC) with insiders at 39% (co-founder DeWitte 14%, Altman ~2-4% or 3.7-6.2 million shares) and institutions ~48% (BlackRock/Vanguard leads) offers aligned incentives but dilution machine vs. NuScale (SMR: $1.3 billion cash on dual-class 285 million shares, ~$460 million FY2025 burn, NRC-approved but low-revenue $32 million)—Oklo's owner-op model burns faster short-term but moats via recycling; NANO Nuclear (NNE: $578 million cash post-$400 million Oct 2025 PP, $37 million annual FCF burn, 52 million shares up 77% since 2024 IPO) mirrors Oklo's raise-spend-raise but lacks Oklo's hyperscaler deals, risking deeper cuts.[5][6][7]
| Metric | Oklo (Q3'25) | NuScale (FY'25) | NANO (Q1'26) |
|--------|--------------|-----------------|--------------|
| Liquidity | $1.18B | $1.3B | $578M |
| Annual Burn | $70M (guide) | $460M ops | $37M FCF |
| Shares (dil.) | 156M | 295M | 52M |
| Insider % | 39% | Lower (pub) | Higher (post-IPO) |
| Debt | $0 | $0 | $0 |
Oklo edges peers on burn efficiency (owner-op data edge) but trails NuScale's certification; to compete, replicate Altman's network for non-dilutive DOE/Meta prepays. Confidence: High on filings; peers estimated from reports—deeper 10-Qs strengthen.
Recent Findings Supplement (March 2026)
Cash Position and Burn Rate (Q3 2025 Latest Filing)
Oklo bolstered its liquidity to $1.184 billion in cash, cash equivalents, and marketable debt securities as of September 30, 2025 (Q3 end), via a $540 million gross proceeds at-the-market (ATM) equity offering completed in Q3—selling ~7.4 million shares at an average ~$73/share—mechanistically extending runway by auto-diluting shares without fixed pricing risk, unlike traditional offerings; this positions the pre-revenue firm for 15+ years at current burn before needing fresh capital, non-obviously insulating against regulatory delays that plague peers.[1][2]
- Cash & equivalents: $410 million (up from $97 million at 2024 year-end); marketable securities: $774 million[1]
- YTD operating cash use (adj. for non-cash items): $49 million; Q3 ops loss $36 million (90% non-cash stock comp); FY2025 guidance reaffirmed at $65-80 million total ops cash use[3]
- No debt/warrants exercised post-SPAC; prior $400 million ATM exhausted August 2025, topped up $140 million September[1]
Q4 2025 / FY results due March 17, 2026—no updates yet, but Q3 runway implies no near-term distress absent capex ramp.[4]
Implication for competitors: Oklo's ATM-fueled war chest dwarfs peers (e.g., NuScale ~$1.3 billion liquidity end-2025 but $460 million annual ops burn, risking faster depletion).[5] New entrants must match this dilution tolerance or partner early, as Oklo's scale funds DOE pilots (Aurora-INL groundbreaking, fuel fab) peers can't afford solo.
Post-SPAC Funding Events (Sep 2025+)
Oklo exhausted its June 2025 $400 million ATM by late August (5.46 million shares), immediately upsizing via prospectus supplement to $540 million total—selling another 1.93 million shares by Sep 11 at ~$73/share—exploiting post-Meta deal momentum for non-dilutive (market-priced) capital infusion without lockups, unlike warrant cash-ins that flood supply at fixed strikes.[1]
- No new shelf/debt announced Q3+; prior $3.5 billion mixed shelf (Nov 2025) enables future flexibility[6]
- Atomic Alchemy acquisition (Feb 2025): $1 million cash + $24 million stock—minor impact[7]
Implication for competitors: Peers like NuScale rely on similar ATMs ($750 million Q4 2025) but face higher scrutiny on revenue ramps; Oklo's hyperscaler prepays (e.g., Meta 1.2 GW Ohio, phase 1 2030) could seed non-dilutive cash others lack, turning data-center deals into moat-builders.[8]
Regulatory Milestones and Dilution Triggers
Public estimates peg Oklo's first Aurora-INL ops late 2027/early 2028 (DOE prototype auth H1 2026), triggering capex ramp (~$1.68 billion Tennessee fuel center Phase 1) and potential $14 billion total by 2040s for owner-operator model—non-obviously pressuring cash if HALEU shortages persist, likely forcing shelf taps/dilution at scale-up.[9][10]
- DOE wins (3 Reactor/Fuel Line Pilots, Pluto radioisotopes H2 2026 revenue); NRC COLA filing early Q4 2025 (18-month review); Centrus JV (Mar 9, 2026) de-risks HALEU deconversion[11]
- Triggers: Fuel fab scale (2026+), 18 GW pipeline conversion (2026 firm PPAs), INL grid tie (post-2027 prototype)—each ~$1-2 billion capex, per owner-op model[12]
Implication for competitors: Oklo's DOE fast-tracks (bypassing full NRC) create 1-2 year leads; rivals must lobby similar or risk dilution death spirals (NuScale $200-460 million annual burn).[13]
Capital Structure and Ownership (Post-Q3 2025)
Institutional ownership ~85% (BlackRock 9.5%, Vanguard 7.5%, Mirae 5.2%), up on ATM buys; insiders ~19% post-sales (DeWitte/Cochran ~200k shares each Mar 2026 under 10b5-1 plans)—Altman resigned board Apr 2025, stake reduced 33% pre-Q3 (no recent 13D/G).[14][15]
- Vs. peers: Oklo's ~156 million shares (23% diluted YTD) less fragmented than NuScale (heavy dilution, $4B cap on $64M rev); both pre-revenue SPACs, but Oklo's hyperscaler ties (Meta prepay) attract quality holders (ARK adds)[16]
Implication for competitors: Oklo's concentrated instos + Altman halo enable patient capital; peers with broader floats face volatility on misses—enter via niche DOE pilots before Oklo locks supply chains.
Recent Announcements (Last 6 Months, Post-9/9/25)
- Mar 9, 2026: Centrus JV for Ohio HALEU deconversion (co-located Meta 1.2 GW)[11]
- Jan 2026: Meta 1.2 GW Ohio PPA (prepay funds dev, 2030 Phase 1); DOE radioisotope pilot[8]
- Q3 2025: INL groundbreaking, 3 DOE pilots, $1.68B TN fuel center[17]
Confidence: High on Q3 data (direct SEC); medium on FY2025 (pending Mar 17); low on Q4 cash (Yahoo $922M mrq est.). Peers verified via cross-checks. Additional SEC 8-Ks would confirm no hidden raises.[18]